About
Andrew Mochalskyy is a technology executive serving as CTO of Deep Origin, an AI-powered drug discovery company based in South San Francisco. Public company materials place him on the executive team of a biotech/software platform focused on computational drug discovery and predictive preclinical models. Available evidence supports an operator and ecosystem role rather than an investor or fund-management role.
Areas of interest
AIbiotechdrug discoverycomputational biologyplatform engineeringlife sciences software